[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR20100106975A - Bactericidal cleanser composition - Google Patents

Bactericidal cleanser composition Download PDF

Info

Publication number
KR20100106975A
KR20100106975A KR1020107013334A KR20107013334A KR20100106975A KR 20100106975 A KR20100106975 A KR 20100106975A KR 1020107013334 A KR1020107013334 A KR 1020107013334A KR 20107013334 A KR20107013334 A KR 20107013334A KR 20100106975 A KR20100106975 A KR 20100106975A
Authority
KR
South Korea
Prior art keywords
polyoxyethylene
detergent composition
mass
foam
ether
Prior art date
Application number
KR1020107013334A
Other languages
Korean (ko)
Other versions
KR101443951B1 (en
Inventor
미미 카와노
타카오 오스기
Original Assignee
라이온 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이온 가부시키가이샤 filed Critical 라이온 가부시키가이샤
Publication of KR20100106975A publication Critical patent/KR20100106975A/en
Application granted granted Critical
Publication of KR101443951B1 publication Critical patent/KR101443951B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/72Ethers of polyoxyalkylene glycols
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/38Cationic compounds
    • C11D1/62Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2006Monohydric alcohols
    • C11D3/201Monohydric alcohols linear
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

(A) 카티온성 살균제, (B-1) HLB9 내지 16의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린 및 모노스테아린산 폴리에틸렌글리콜로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 16 내지 40질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물.(A) a cationic fungicide, (B-1) nonionic surfactant selected from polyoxyethylene hardened castor oil of HLB9-16, monostearic acid polyoxyethyleneglycerin and monostearic acid polyethyleneglycol, (C) amino acid or its salt, And (D) 16 to 40% by mass of alcohols having 1 to 3 carbon atoms, which are filled in a former container and discharged in the form of bubbles, wherein the disinfecting detergent composition of the non-washable type is used.

Description

살균 청정제 조성물{BACTERICIDAL CLEANSER COMPOSITION}Bactericidal Detergent Composition {BACTERICIDAL CLEANSER COMPOSITION}

본 발명은, 거품으로 사용하는 씻어내지 않는 타입의 살균 청정제 조성물에 관한 것이다.The present invention relates to a sterilizing detergent composition of a non-washable type used in foam.

종래의 살균제 세제에서는 씻어내는 것이 주류여서, 외출처나 거실 등 물이 없는 곳에서의 사용은 곤란하고, 그 제형(劑型)은 젤상(狀)(특허문헌1 : 일본 특허 제3499882호 공보 참조)이나 스프레이상(狀)이였다. 그러나, 젤상의 소독제는, 첨가하고 있는 증점제에 의해 사용 후에 끈적거림이 남는 등의 사용감(使用感)에서 문제가 있고, 스프레이상의 것은 바닥(상(床) 등에 흩어지는 등의 사용성에 문제가 있다. 한편, 살균 청정제를 거품으로 하는 기술이 제안되어 있는데(특허문헌2 : 일본 특개평10-330799호 공보, 특허문헌3 : 일본 특개2001-139993호 공보, 특허문헌4 : 일본 특개소62-135410호 공보 참조), 늦게 마르고, 손에 편 후에도 거품이 남거나, 거품 보형성(保形性)이 나쁘다는 문제가 있다. 이상의 것으로부터, 손에 취한 때는 거품 보형성이 있어서 손으로부터 잘 떨어지지 않고, 손에 편 후는, 적당한 시간에 거품이 꺼지고, 거품 찌꺼기가 없으며, 또한 건조가 용이한, 거품으로 사용하는 씻어내지 않는 타입의 살균 청정제 조성물이 요망되고 있다.In conventional disinfectant detergents, washing is the mainstream, so it is difficult to use it in a place without water such as in the outside or living room, and the dosage form is gel-like (see Patent Document 1: Japanese Patent No. 3499882) It was a spray form. However, the gel disinfectant has a problem in feeling of use such as stickiness after use by the thickener added, and the spray form has a problem in usability such as scattering on the bottom or the like. On the other hand, there has been proposed a technique of using a sterilizing detergent as a foam (Patent Document 2: Japanese Patent Application Laid-Open No. 10-330799, Patent Document 3: Japanese Patent Application Laid-Open No. 2001-139993, Patent Document 4: Japanese Patent Application Laid-Open No. 62-135410). ), There is a problem that it dries late, bubbles remain even after opening, or foam retention is poor. After the hand is opened, a non-washable type of antiseptic detergent composition for use in a foam is desired that foam is extinguished at a suitable time, is free of debris, and is easy to dry.

특허문헌1 : 일본 특허 제3499882호 공보Patent Document 1: Japanese Patent No. 3499882 특허문헌2 : 일본 특개평10-330799호 공보Patent Document 2: Japanese Patent Application Laid-Open No. 10-330799 특허문헌3 : 일본 특개2001-139993호 공보Patent Document 3: Japanese Patent Application Laid-Open No. 2001-139993 특허문헌4 : 일본 특개소62-135410호 공보Patent Document 4: Japanese Patent Application Laid-Open No. 62-135410

본 발명은 상기 사정을 감안하여 이루어진 것으로, 손에 취한 때는 거품 보형성이 있어서 손으로부터 잘 떨어지지 않고, 손에 편 후는, 적당한 시간에 거품이 꺼지고, 거품 찌꺼기가 없으며 또한 건조가 용이한, 씻어내지 않는 타입의 살균 청정제 조성물을 제공하는 것을 목적으로 한다.SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and when it is taken by hand, it has foam retention and does not fall off from the hand easily. After it is opened, the foam is turned off at a suitable time, there is no bubble residue, and it is easy to dry. It is an object of the present invention to provide a sterile detergent composition of the type that does not.

본 발명자들은, 상기 목적을 달성하기 위해 예의 검토한 결과, 카티온성 살균제를 함유하는 살균 청정제 조성물에, 특정한 비이온성 계면활성제와 아미노산 또는 그 염의 조합에 의해, 탄소수 1 내지 3의 알코올을 배합하여도, 손에 취한 때는 거품 보형성이 있어서 손으로부터 잘 떨어지지 않는 성질을 갖는 한편, 손에 편 후는, 적당한 시간에서 거품이 꺼지고, 거품 찌꺼기가 없고 또한 건조가 용이한 씻어내지 않는 타입의 살균 청정제 조성물을 얻을 수 있는 것을 발견하고, 본 발명을 이루는데 이르런 것이다. 손에 취한 때에 거품의 잘 떨어지지 않음은, 거품의 보형성과 상관이 있고, 보형성이 양호한 것일수록 손에 취한 때 거품은 잘 떨어지지 않고, 사용성이 양호하다. 한편으로, 손에 취한 거품이 적당한 시간에서 사라지고 유동성이 있는 액체가 됨에 의해, 손가락에 문질러 바르기 쉽고, 사용성이 양호하게 된다. 이와 같이 본 발명의 구성으로 함에 의해 특별한 작용 효과가 발휘된 것은, 상기 종래 기술로부터는 예상하기 어려운 것이고, 본 발명자가 새롭게 발견한 것이다.MEANS TO SOLVE THE PROBLEM As a result of earnestly examining in order to achieve the said objective, even if it mix | blends a C1-C3 alcohol with the combination of a specific nonionic surfactant, an amino acid, or its salt, in the bactericidal detergent composition containing a cationic fungicide, In the case of hand-washing, it has a foam retaining property and does not easily fall off from the hand, while after hand-opening, the foam is turned off at a suitable time, and there is no bubble residue and it is easy to dry. It is found that can be obtained, and came to achieve the present invention. Poor dropping of the foam when taken by hand is correlated with the shape retention of the foam. The better the shape retention, the better the bubble does not fall when taken by hand, and the usability is good. On the other hand, since the foam taken by hand disappears at a suitable time and becomes a fluid liquid, it is easy to rub on a finger and the usability becomes good. Thus, it is difficult to anticipate from the said prior art, and the inventors newly discovered that the special effect was exhibited by setting it as the structure of this invention.

따라서 본 발명은 하기 살균 청정제 조성물을 제공한다.Accordingly, the present invention provides the following sterile detergent composition.

[1]. (A) 카티온성 살균제, (B-1) HLB9 내지 16의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린 및 모노스테아린산 폴리에틸렌글리콜로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 16 내지 40질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물.[One]. (A) a cationic fungicide, (B-1) nonionic surfactant selected from polyoxyethylene hardened castor oil of HLB9-16, monostearic acid polyoxyethyleneglycerin and monostearic acid polyethyleneglycol, (C) amino acid or its salt, And (D) 16 to 40% by mass of alcohols having 1 to 3 carbon atoms, which are filled in a former container and discharged in the form of bubbles, wherein the disinfecting detergent composition of the non-washable type is used.

[2]. (A) 카티온성 살균제, (B-2) HLB10 내지 14의 하기 일반식(1)[2]. (A) Cationic fungicide, (B-2) the following general formula (1) of HLB10-14

Figure pct00001
Figure pct00001

(식 중, m은 6 내지 10, n은 10 내지 25의 정수를 나타낸다.)(In formula, m is 6-10, n represents the integer of 10-25.)

로 표시되는 폴리옥시에틸렌 분기(分岐) 알킬에테르 및 폴리옥시에틸렌콜레스테릴에테르로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 30 내지 70질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물.Nonionic surfactants selected from polyoxyethylene branched alkyl ethers and polyoxyethylene cholesteryl ethers, (C) amino acids or salts thereof, and (D) 30 to 70 masses of alcohols having 1 to 3 carbon atoms. A sterilizing detergent composition of a non-washable type, comprising% and filled in a foamer container and discharged in a foam form.

[3]. (A)성분이, 염화 벤잘코늄, 염화 벤제토늄 또는 염화 세틸피리디늄인 [1] 또는 [2]에 기재된 살균 청정제 조성물.[3]. The sterilizing detergent composition as described in [1] or [2] whose (A) component is benzalkonium chloride, benzetonium chloride, or cetylpyridinium chloride.

본 발명에 의하면, 손에 취한 때는 거품 보형성이 있어서 손으로부터 잘 떨어지지 않는다는 성질을 갖는 한편, 손에 바른 후는, 적당한 시간에서 거품이 꺼지고, 거품 찌꺼기가 없고 또한 건조가 용이한 거품으로 사용하는 씻어내지 않는 타입의 살균 청정제 조성물을 제공할 수 있다.According to the present invention, it has a property of having foam retaining properties when it is taken by hand and does not easily fall off from the hand. On the other hand, after being applied to the hand, the foam is turned off at a suitable time, and it is used as a foam which is free of debris and easy to dry. A sterile detergent composition of the type which does not wash off can be provided.

이하, 본 발명에 관해 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명의 제 1의 살균 청정제 조성물은, (A) 카티온성 살균제, (B-1) HLB9 내지 16의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린 및 모노스테아린산 폴리에틸렌글리콜로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 16 내지 40질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물이고, 제 2의 살균 청정제 조성물은, (A) 카티온성 살균제, (B-2) HLB10 내지 14의 일반식(1)으로 표시되는 폴리옥시에틸렌 분기 알킬에테르 및 폴리옥시에틸렌콜레스테릴에테르로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 30 내지 70질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물이다.The first bactericidal detergent composition of the present invention is a nonionic selected from (A) cationic fungicide, (B-1) polyoxyethylene cured castor oil of HLB9-16, monostearic acid polyoxyethyleneglycerin and monostearic acid polyethylene glycol It contains a surfactant, (C) an amino acid or its salt, and (D) 16-40 mass% of C1-C3 alcohols, is made to fill a former container, and is discharged in foam form, and is not wash | cleaned. A type of bactericidal detergent composition, wherein the second bactericidal detergent composition is (A) a cationic bactericide, (B-2) polyoxyethylene branched alkyl ether and polyoxyethylene chole represented by the general formula (1) of HLB10 to 14 A nonionic surfactant selected from styryl ether, (C) amino acid or salt thereof, and (D) 30 to 70% by mass of alcohol having 1 to 3 carbon atoms are charged, It made and the sterilization of the detergent composition characterized in that the discharge of foam shape, that is to wash type.

(A) 카티온성 살균제(A) cationic fungicide

카티온성 살균제로서는, 하기 일반식(2) 또는 (3)으로 표시되는 것을 들 수 있고, 1종 단독으로 또는 2종 이상을 병용할 수 있다.As a cationic fungicide, what is represented by following General formula (2) or (3) is mentioned, One type can be used individually or 2 or more types can be used together.

Figure pct00002
Figure pct00002

[식중, R1 및 R2은 각각, 탄소수 8 내지 18의 알킬기, 알켄일기 또는 에테르 결합을 갖는 탄화 수소기를 나타내고, X 및 Y는 각각, 할로겐 원자, 아미노산 또는 지방산을 나타낸다.][Wherein, R 1 and R 2 each represent an alkyl group having 8 to 18 carbon atoms, an alkenyl group or a hydrocarbon group having an ether bond, and X and Y each represent a halogen atom, an amino acid or a fatty acid.]

일반식(2)로 표시되는 것으로서는, 염화 벤잘코늄, 염화 벤제토늄 등을 들 수 있고, 일반식(3)으로 표시되는 것으로서는 염화 세틸피리디늄 등을 들 수 있다. 그 중에서도, 거품의 보형성의 점에서, 염화 벤잘코늄, 염화 세틸피리디늄이 바람직하다.Examples of the compound represented by the general formula (2) include benzalkonium chloride and benzethonium chloride, and examples of the compound represented by the general formula (3) include cetylpyridinium chloride and the like. Especially, benzalkonium chloride and cetylpyridinium chloride are preferable at the point of the shape retention of foam.

(A)성분의 배합량(2종 이상을 병용하는 경우는 합계량)은, 살균 청정제 조성물중 0.01 내지 1질량%가 바람직하고, 보다 바람직하게는 0.01 내지 0.5질량%이다. 0.01질량% 미만에서는 살균 성능이 불충분하게 될 우려가 있고, 1질량%를 초과하여 배합하여도 살균 성능으로서 과잉량이 되거나, 손을 맞비빈 후에 거품 찌꺼기가 있거나 할 우려가 있다.As for the compounding quantity ((total amount when using 2 or more types together) of (A) component, 0.01-1 mass% is preferable in a sterilizing detergent composition, More preferably, it is 0.01-0.5 mass%. If it is less than 0.01 mass%, there exists a possibility that sterilization performance may become inadequate, and even if it mix | blends more than 1 mass%, it may become excessive amount as sterilization performance, or there may be a bubble residue after hand rub.

(B-1) HLB9 내지 16의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린 및 모노스테아린산 폴리에틸렌글리콜로부터 선택되는 비이온성 계면활성제(B-1) Nonionic surfactant selected from polyoxyethylene hardened castor oil, monostearic acid polyoxyethyleneglycerin and monostearic acid polyethyleneglycol of HLB9-16

HLB9 내지 16의 폴리옥시에틸렌 경화피마자유(이하, 폴리옥시에틸렌을 POE라고 약기하는 경우가 있다.)로서는, 예를 들면, 폴리옥시에틸렌(20) 경화피마자유(HLB9), 폴리옥시에틸렌(30) 경화피마자유(HLB11), 폴리옥시에틸렌(40) 경화피마자유(HLB12), 폴리옥시에틸렌(50) 경화피마자유(HLB13), 폴리옥시에틸렌(60) 경화피마자유(HLB14), 폴리옥시에틸렌(80) 경화피마자유(HLB15), 폴리옥시에틸렌(100) 경화피마자유(HLB15)를 들 수 있다.As polyoxyethylene hydrogenated castor oil of HLB9-16 (Hereinafter, polyoxyethylene may abbreviate as POE.) For example, polyoxyethylene (20) hydrogenated castor oil (HLB9), polyoxyethylene (30 ) Cured Castor Oil (HLB11), Polyoxyethylene (40) Cured Castor Oil (HLB12), Polyoxyethylene (50) Cured Castor Oil (HLB13), Polyoxyethylene (60) Cured Castor Oil (HLB14), Polyoxyethylene (80) hydrogenated castor oil (HLB15) and polyoxyethylene (100) hydrogenated castor oil (HLB15).

HLB9 내지 16의 모노스테아린산 폴리옥시에틸렌글리세린으로서는, 폴리옥시에틸렌(5) 글리세릴모노스테아레이트(이하, 스테아린산 PEG-5 글리세릴(HLB9)로 나타낸다.), 스테아린산 PEG-10 글리세릴(HLB11), 스테아린산 PEG-15 글리세릴(HLB13), 스테아린산 PEG-20 글리세릴(HLB14), 스테아린산 PEG-30 글리세릴(HLB15), 스테아린산 PEG-40 글리세릴(HLB16) 등을 들 수 있다.As monostearic acid polyoxyethylene glycerin of HLB9-16, polyoxyethylene (5) glyceryl monostearate (henceforth represented by stearic acid PEG-5 glyceryl (HLB9)), stearic acid PEG-10 glyceryl (HLB11), Stearic acid PEG-15 glyceryl (HLB13), stearic acid PEG-20 glyceryl (HLB14), stearic acid PEG-30 glyceryl (HLB15), stearic acid PEG-40 glyceryl (HLB16), and the like.

HLB9 내지 16의 모노스테아린산 폴리에틸렌글리콜로서는, 폴리옥시에틸렌(10) 모노스테아레이트(이하, 스테아린산 PEG-10(HLB11)로 나타낸다.), 스테아린산 PEG-20(HLB14), 스테아린산 PEG-30(HLB15), 스테아린산 PEG-40(HLB16)을 들 수 있다.As monostearic acid polyethyleneglycol of HLB9-16, polyoxyethylene (10) monostearate (it shows as stearic acid PEG-10 (HLB11) hereafter), stearic acid PEG-20 (HLB14), stearic acid PEG-30 (HLB15), Stearic acid PEG-40 (HLB16).

본 발명의 HLB9 내지 16의 상기 비이온성 계면활성제는 1종 단독으로 또는 2종 이상을 적절히 조합시켜서 사용할 수 있다. 그 중에서도, HLB12 내지 15의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린, 모노스테아린산 폴리에틸렌글리콜이 바람직하고, 예를 들면, 폴리옥시에틸렌(40) 경화피마자유(HLB12), 폴리옥시에틸렌(50) 경화피마자유(HLB13), 폴리옥시에틸렌(60) 경화피마자유(HLB14), 폴리옥시에틸렌(80) 경화피마자유(HLB15), 폴리옥시에틸렌(100) 경화피마자유(HLB15), 스테아린산 PEG-15 글리세릴(HLB13), 스테아린산 PEG-20 글리세릴(HLB14), 스테아린산 PEG-30 글리세릴(HLB15), 스테아린산 PEG-20(HLB14), 스테아린산 PEG-30(HLB15)을 들 수 있다. (B-1)의 비이온성 계면활성제에서는, HLB9 미만에서는, 거품의 보형성이 나빠지고, HLB16을 초과하여도, 거품의 보형성이 나빠지는 경우가 있다.The said nonionic surfactant of HLB9-16 of this invention can be used individually by 1 type or in combination of 2 or more types. Especially, polyoxyethylene hardened castor oil of HLB12-15, polyoxyethylene glycerin monostearate, polyethyleneglycol monostearate is preferable, For example, polyoxyethylene (40) hardened castor oil (HLB12), polyoxyethylene ( 50) Cured Castor Oil (HLB13), Polyoxyethylene (60) Cured Castor Oil (HLB14), Polyoxyethylene (80) Cured Castor Oil (HLB15), Polyoxyethylene (100) Cured Castor Oil (HLB15), Stearic Acid PEG -15 glyceryl (HLB13), stearic acid PEG-20 glyceryl (HLB14), stearic acid PEG-30 glyceryl (HLB15), stearic acid PEG-20 (HLB14), stearic acid PEG-30 (HLB15). In the nonionic surfactant of (B-1), below HLB9, foam retaining property worsens, and even if it exceeds HLB16, foam retaining property may worsen.

(B-2) HLB10 내지 14의 하기 일반식(1)으로 표시되는 폴리옥시에틸렌 분기 알킬에테르 및 폴리옥시에틸렌콜레스테릴에테르로부터 선택되는 비이온성 계면활성제(B-2) Nonionic surfactant chosen from polyoxyethylene branched alkyl ether and polyoxyethylene cholesteryl ether represented by following General formula (1) of HLB10-14

Figure pct00003
Figure pct00003

(식중, m은 6 내지 10, n은 10 내지 25의 정수를 나타낸다.)(Wherein m represents 6 to 10 and n represents an integer of 10 to 25).

일반식(1)으로 표시되는 폴리옥시에틸렌 분기 알킬에테르로서는, 예를 들면 하기한 것을 들 수 있다.As polyoxyethylene branched alkyl ether represented by General formula (1), the following are mentioned, for example.

m=6, n=10 : 폴리옥시에틸렌(10) 이소세틸에테르(HLB11)m = 6, n = 10: polyoxyethylene (10) isocetyl ether (HLB11)

m=6, n=15 : 폴리옥시에틸렌(15) 이소세틸에테르(HLB13)m = 6, n = 15: polyoxyethylene (15) isocetyl ether (HLB13)

m=6, n=20 : 폴리옥시에틸렌(20) 이소세틸에테르(HLB14)m = 6, n = 20: polyoxyethylene (20) isocetyl ether (HLB14)

m=7, n=10 : 폴리옥시에틸렌(10) 이소스테아릴에테르(HLB11)m = 7, n = 10: polyoxyethylene (10) isostearyl ether (HLB11)

m=7, n=15 : 폴리옥시에틸렌(15) 이소스테아릴에테르(HLB12)m = 7, n = 15: polyoxyethylene (15) isostearyl ether (HLB12)

m=7, n=20 : 폴리옥시에틸렌(20) 이소스테아릴에테르(HLB13)m = 7, n = 20: polyoxyethylene (20) isostearyl ether (HLB13)

m=7, n=25 : 폴리옥시에틸렌(25) 이소스테아릴에테르(HLB14)m = 7, n = 25: polyoxyethylene (25) isostearyl ether (HLB14)

m=8, n=10 : 폴리옥시에틸렌(10) 옥틸도데실에테르(HLB10)m = 8, n = 10: polyoxyethylene (10) octyldodecyl ether (HLB10)

m=8, n=16 : 폴리옥시에틸렌(16) 옥틸도데실에테르(HLB12)m = 8, n = 16: polyoxyethylene (16) octyldodecyl ether (HLB12)

m=8, n=20 : 폴리옥시에틸렌(20) 옥틸도데실에테르(HLB13)m = 8, n = 20: polyoxyethylene (20) octyldodecyl ether (HLB13)

m=8, n=25 : 폴리옥시에틸렌(25) 옥틸도데실에테르(HLB14)m = 8, n = 25: polyoxyethylene (25) octyldodecyl ether (HLB14)

m=10, n=15 : 폴리옥시에틸렌(15) 데실테트라데실에테르(HLB11)m = 10, n = 15: Polyoxyethylene (15) decyl tetradecyl ether (HLB11)

m=10, n=20 : 폴리옥시에틸렌(20) 데실테트라데실에테르(HLB12)m = 10, n = 20: polyoxyethylene (20) decyl tetradecyl ether (HLB12)

m=10, n=25 : 폴리옥시에틸렌(25) 데실테트라데실에테르(HLB13)m = 10, n = 25: polyoxyethylene (25) decyl tetradecyl ether (HLB13)

그 중에서도, HLB10 내지 13의 것이 거품의 보형성의 점에서 바람직하고, 구체적으로는, 폴리옥시에틸렌(10) 옥틸도데실에테르(HLB10), 폴리옥시에틸렌(16) 옥틸도데실에테르(HLB12), 폴리옥시에틸렌(20) 옥틸도데실에테르(HLB13), 폴리옥시에틸렌(15) 데실테트라데실에테르(HLB11), 폴리옥시에틸렌(20) 데실테트라데실에테르(HLB12), 폴리옥시에틸렌(25) 데실테트라데실에테르(HLB13)이다. (B-2)의 비이온성 계면활성제에서는, HLB10 미만에서는, 거품의 보형성이 나빠지고, HLB14를 초과하여도, 거품의 보형성이 나빠지는 경우가 있다.Especially, HLB10-13 are preferable at the point of the shape retention of foam, Specifically, polyoxyethylene (10) octyl dodecyl ether (HLB10), polyoxyethylene (16) octyl dodecyl ether (HLB12), Polyoxyethylene (20) octyldodecyl ether (HLB13), polyoxyethylene (15) decyl tetradecyl ether (HLB11), polyoxyethylene (20) decyl tetradecyl ether (HLB12), polyoxyethylene (25) decyl tetra Decyl ether (HLB13). In the nonionic surfactant of (B-2), below HLB10, foam retaining property worsens, and even if it exceeds HLB14, foam retaining property may worsen.

폴리옥시에틸렌콜레스테릴에테르으로서는, 폴리옥시에틸렌콜레스테릴에테르으로서는, 폴리옥시에틸렌(10) 콜레스테릴에테르(HLB10), 폴리옥시에틸렌(15) 콜레스테릴에테르(HLB11), 폴리옥시에틸렌(20) 콜레스테릴에테르(HLB12), 폴리옥시에틸렌(24) 콜레스테릴에테르(HLB13), 폴리옥시에틸렌(30) 콜레스테릴에테르(HLB14) 등을 들 수 있고, 그 중에서도 폴리옥시에틸렌(10) 콜레스테릴에테르(HLB10), 폴리옥시에틸렌(15) 콜레스테릴에테르(HLB11), 폴리옥시에틸렌(20) 콜레스테릴에테르(HLB12)가 특히 바람직하다. 또한, () 내는 에틸렌옥시드의 평균 부가 몰수를 나타낸다.As polyoxyethylene cholesteryl ether, as polyoxyethylene cholesteryl ether, polyoxyethylene (10) cholesteryl ether (HLB10), polyoxyethylene (15) cholesteryl ether (HLB11), polyoxyethylene ( 20) cholesteryl ether (HLB12), polyoxyethylene (24) cholesteryl ether (HLB13), polyoxyethylene (30) cholesteryl ether (HLB14), and the like, and polyoxyethylene (10). Cholesteryl ether (HLB10), polyoxyethylene (15) cholesteryl ether (HLB11), and polyoxyethylene (20) cholesteryl ether (HLB12) are particularly preferred. In addition, () shows the average added mole number of ethylene oxide.

또한, HLB치(値)란, 계면활성제를 구성하고 있는 친수기와 소수기의 강함의 밸런스를 나타내는 값이고, 산출법은 하기 가와가미(流上)의 식(式)에 의한다.In addition, an HLB value is a value which shows the balance of the strength of the hydrophilic group and hydrophobic group which comprise surfactant, and a calculation method is based on the formula of the following Kawagami.

HLB치=7+11.7log(MW/MO)HLB value = 7 + 11.7 log (M W / M O )

MW : 계면활성제 친수(親水) 부분의 분자량M W : Molecular Weight of Surfactant Hydrophilic Part

MO : 계면활성제 친유(親油) 부분의 분자량M O : Molecular weight of surfactant lipophilic part

(B-1) 및 (B-2)성분의 배합량(2종 이상을 병용하는 경우는 합계량)은, 살균 청정제 조성물중 0.01 내지 1.0질량%가 바람직하고, 0.1 내지 0.5질량%가 거품의 보형성, 손을 맞비빈 후의 거품 찌꺼기 없음의 점에서 보다 바람직하다. 0.01질량% 미만에서는, 거품의 보형성이 불충분하게 될 우려가 있고, 1.0질량%를 초과하면 사용 후에 끈적거림이 생기거나, 손을 맞 비빈 후의 거품 찌꺼기가 잔류할 우려가 있다.As for the compounding quantity (total amount when using 2 or more types together) of (B-1) and (B-2) component, 0.01-1.0 mass% is preferable in a sterilizing detergent composition, and 0.1-0.5 mass% is the shape retention of foam. It is more preferable at the point that there is no bubble dreg after putting hands together. If it is less than 0.01 mass%, foam retention may become inadequate, and if it exceeds 1.0 mass%, stickiness may occur after use or foam residue after rubbing hands may remain.

(C) 아미노산 또는 그 염(C) amino acids or salts thereof

본 발명의 아미노산으로서는, 글리신, 리신, 세린, 프롤린, 아르기닌, 글루타민산 등, 및 피롤리돈카르본산의 아미노산 유도체 등을 들 수 있고, 이들은 1종 단독으로 또는 2종 이상을 적절히 조합시켜서 사용할 수 있다. 염으로서는, 예를 들면, 알칼리 금속, 알칼리토류 금속 등을 들 수 있다. 그 예로서, 글루타민산 나트륨, dl-피롤리돈카르본산 나트륨 등을 들 수 있다. 그 중에서도, 거품 보형성의 점에서, dl-피롤리돈카르본산 나트륨, 리신, 세린, 글리신이 바람직하고, 특히 dl-피롤리돈카르본산 나트륨이 바람직하다.Examples of the amino acids of the present invention include glycine, lysine, serine, proline, arginine, glutamic acid and the like, and amino acid derivatives of pyrrolidone carboxylic acid. These may be used alone or in combination of two or more thereof as appropriate. . As a salt, an alkali metal, alkaline earth metal, etc. are mentioned, for example. Examples thereof include sodium glutamate, sodium dl-pyrrolidone carboxylate, and the like. Among these, sodium dl-pyrrolidone carbonate, lysine, serine, and glycine are preferable, and sodium dl-pyrrolidone carboxylic acid is particularly preferable from the viewpoint of foam retention.

(C)성분의 배합량(2종 이상을 병용하는 경우는 합계량)은, 살균 청정제 조성물중 0.01 내지 5질량%가 바람직하고, 0.1 내지 1질량%가 또한 바람직하다. 0.01질량% 미만에서는, 손에 취한 거품이 적당한 시간에서 사라지기 어렵고, 거품 찌꺼기 없음이 못할 우려가 있고, 5질량%를 초과하면 토출시의 거품 보형성이 불충분하게 될 우려가 있다.As for the compounding quantity ((total amount when using 2 or more types together) of (C) component, 0.01-5 mass% is preferable in sterilizing detergent composition, and 0.1-1 mass% is further more preferable. If the amount is less than 0.01% by mass, the foam taken by hand may be difficult to disappear at a suitable time, and there may be no bubble residue. If the amount exceeds 5% by mass, foam retention may be insufficient at the time of discharge.

(D) 탄소수 1 내지 3의 알코올(D) alcohols having 1 to 3 carbon atoms

탄소수 1 내지 3의 알코올으로서는, 에틸알코올, 이소프로필알코올 등을 들 수 있고, 1종 단독으로 또는 2종 이상을 적절히 조합시켜서 사용할 수 있다. 그 중에서도, 사용시의 냄새의 점에서, 에틸알코올이 바람직하다.Ethyl alcohol, isopropyl alcohol, etc. are mentioned as C1-C3 alcohol, It can be used individually by 1 type or in combination of 2 or more types. Especially, ethyl alcohol is preferable at the point of the odor at the time of use.

본 발명의 제 1의 살균 청정제 조성물에서는, (D)성분의 배합량(2종 이상을 병용하는 경우는 합계량)은, 살균 청정제 조성물중 16 내지 40질량%이고, 거품의 보형성, 손을 맞 비빈 후의 거품 찌꺼기 없음의 점에서 20 내지 30질량%가 바람직하다. 16질량% 미만에서는 건조 용이성이 나쁘고, 또한 40질량%를 초과하면, 포머 용기로부터 토출하여도 거품형상이 되지 않고, 손에 취하기 어렵거나, 곧바로 액상이 되어 손으로부터 떨어져 버린다는 부적합함이 생기는 경우가 있다.In the 1st sterilizing detergent composition of this invention, the compounding quantity ((total amount in the case of using 2 or more types) together) of (D) component is 16-40 mass% in a sterilizing detergent composition, and it is a shape | molding foam and rubs a hand together 20-30 mass% is preferable at the point of no post-waste debris. When less than 16 mass%, the ease of drying is bad, and when it exceeds 40 mass%, when it discharges from a former container, it does not become a bubble shape, it is difficult to get it, or it becomes a liquid immediately, and it becomes unsuitable to fall out of a hand when it arises. There is.

본 발명의 제 2의 살균 청정제 조성물에서는, (D)성분의 배합량(2종 이상을 병용하는 경우는 합계량)은, 살균 청정제 조성물중 30 내지 70질량%이고, 거품의 보형성 및 손을 맞비빈 후의 거품 찌꺼기 없음이라는 점에서, 30 내지 50질량%가 바람직하다. 50질량%이상에서는, 건조 용이성이 특히 바람직하다. 30질량% 미만에서는 손을 맞 비빈 후도, 적당한 시간에서 거품이 꺼지지 않고 거품이 남아 버리는 경우가 있고, 또한 70질량%를 초과하면, 포머 용기로부터 토출하여도 거품형상이 되지 않고, 손에 취하기 어렵거나, 곧바로 액상이 되고 손으로부터 떨어져 버린다는 부적합함이 생기는 경우가 있다.In the 2nd sterilizing detergent composition of this invention, the compounding quantity ((total amount in the case of using 2 or more types) together) of (D) component is 30-70 mass% in a sterilizing detergent composition, and it is a foam retention and hand 30-50 mass% is preferable at the point of no lather afterwards. At 50 mass% or more, easiness of drying is especially preferable. If it is less than 30 mass%, even if it rubs a hand, foam may not remain extinguished at a suitable time, and if it exceeds 70 mass%, even if it discharges from a foamer container, it will not become a foam and will get in a hand It may be difficult or inadequate to become liquid immediately and fall away from the hand.

본 발명의 살균 청정제 조성물에는, 본 발명의 효과를 손상시키지 않는 범위에서 임의의 성분을 배합할 수 있다. 임의의 성분으로서는, 예를 들면, 다가(多價)알코올 등의 용제, (A)성분 및 (D)성분을 제외한 살균제, 수용성 고분자 화합물, 글리시리진산 2칼륨 등의 소염제, 항료, 청량제, 냉량제, 착색료, 유분(油分), 실리콘류, 비타민 등의 약제, 소르비톨, 에리스리톨 등의 당(糖)알코올, 백탁제, 산화 방지제, 금속 봉쇄제, 동식물 추출물 또는 그 유도체, 무기 분체, 점토광물, 나일론, 폴리에틸렌 등의 수불용성 폴리머 분체, 물 등을 들 수 있다. 이들은, 각각 1종 단독으로 또는 2종 이상을 적절히 조합시켜서 사용할 수 있고, 본 발명의 효과를 손상시키지 않는 범위에서 적량 배합할 수 있다.Any component can be mix | blended with the germicidal detergent composition of this invention in the range which does not impair the effect of this invention. As an optional component, For example, solvents, such as a polyhydric alcohol, the fungicide except the (A) component and (D) component, an anti-inflammatory agent, such as a water-soluble high molecular compound and dipotassium glycyrrhinate, a coloring agent, a refreshing agent, and a coolant , Coloring agents, oils, silicones, pharmaceuticals such as vitamins, sugar alcohols such as sorbitol and erythritol, whitening agents, antioxidants, metal blockers, animal and vegetable extracts or derivatives thereof, inorganic powders, clay minerals, nylon And water-insoluble polymer powders such as polyethylene, water, and the like. These can be used individually by 1 type or in combination of 2 or more types, respectively, and can mix suitably in the range which does not impair the effect of this invention.

다가알코올로서는, 폴리에틸렌글리콜, 1,3-부틸렌글리콜, 글리세린 등을 들 수 있고, 0 내지 5질량% 배합하는 것이 바람직하다. 다가알코올의 배합에서, 피부의 버석거림을 방지할 수 있는 것이지만, 5질량%를 초과하여 배합하면, 사용 후에 피부의 끈적거림이 생길 우려가 있다.As polyhydric alcohol, polyethyleneglycol, 1, 3- butylene glycol, glycerin, etc. are mentioned, It is preferable to mix | blend 0-5 mass%. Although blending of polyhydric alcohols can prevent skin bumps, blending in excess of 5% by mass may cause skin stickiness after use.

(A)성분 및 (D)성분을 제외한 살균제로서는, 이소프로필메틸페놀, 트리클로산, 트리클로로카르바닐리드, 염산 크로르헥시딘, 알킬디아미노에틸글리신, 옥토피록스 등을 들 수 있다.Examples of the disinfectant except for the component (A) and the component (D) include isopropylmethylphenol, triclosan, trichlorocarbanilide, chlorhexidine hydrochloride, alkyldiaminoethylglycine, and octopyrox.

수용성 고분자 화합물로서는, 아크릴산 알킬 공중합체 등의 아니온성 고분자 화합물, 카티온화 셀룰로오스, 염화 디메틸디알릴암모늄·아크릴아미드 공중합체, 카티온 변성 구아껌 등의 카티온성 고분자 화합물, 히드록시프로필메틸셀룰로오스, 아세트산 비닐·비닐피롤리돈 공중합체등의 비이온성 고분자 화합물, 디메틸알릴 4급염·아크릴산 아크릴아미드비닐피롤리돈N·N-디메틸아미노에틸 등의 양성(兩性) 폴리머 등을 들 수 있다.As a water-soluble high molecular compound, anionic high molecular compounds, such as an alkyl acrylate copolymer, cationic cellulose, dimethyl diallyl ammonium acrylamide copolymer, cationic high molecular compounds, such as a cation modified guar gum, hydroxypropyl methyl cellulose, acetic acid Nonionic high molecular compounds such as vinyl vinylpyrrolidone copolymer, amphoteric polymers such as dimethylallyl quaternary salt, acrylamide acrylamide vinylpyrrolidone N, N-dimethylaminoethyl, and the like.

항료로서는, 항료 성분, 항료용 용제 및 항료 안정화제로 이루어지는 항료 조성물을 사용할 수 있고, 항료 조성물의 함유량으로서는, 살균 청정제 조성물중 0.005 내지 40질량%가 바람직하고, 0.01 내지 10질량%가 보다 바람직하다. 항료 성분으로서 사용된 항료 원료의 리스트는, 다양한 문헌, 예를 들면, 「Perfume and Flavor Chemicals」, Vol. I and Ⅱ, Steffen Arctander, Allured Pub. Co. (1994) ; 「합성 항료 화학과 상품 지식」, 인도우모토이치 저, 화학공업 일보사(1996) ; 「Perfume and Flavor Materials of Natural Origin」, Steffen Arctander, Allured Pub. Co. (1994) ; 「향기의 백과」, 일본항료협회 편, 아사쿠라 서점(1989) ; 「Perfumery Material Performance V. 3.3」, Boelens Aroma Chemical Information Service(1996) ; 「Flower oils and Floral Compounds In Perfumery」, Danute Lajaujis Anonis, Allured Pub. Co. (1993) 등을 들 수 있고, 예를 들면, 이들의 문헌에 기재된 항료 원료 중에서, 상기 항료 성분을 적절히 선택할 수 있다. 구체적으로는, 예를 들면, 유칼리 유, 캄퍼, 보르네올, 레몬 유, 라임 유, 그레이프프루츠 엑기스, 라벤더 유, 라벤더 엑기스, 로즈마리 유, 로즈마리 엑기스 등을 들 수 있다.As a coating agent, the coating composition which consists of a coating component, a solvent for a coating agent, and a coating stabilizer can be used. As content of a coating composition, 0.005-40 mass% is preferable in a sterilizing detergent composition, and 0.01-10 mass% is more preferable. A list of pharmaceutical raw materials used as pharmaceutical ingredients is described in various literatures such as "Perfume and Flavor Chemicals", Vol. I and II, Steffen Arctander, Allured Pub. Co. (1994); "Composite Chemicals and Product Knowledge," Indo-Umotoichi, Chemical Industry Daily (1996); Perfume and Flavor Materials of Natural Origin, Steffen Arctander, Allured Pub. Co. (1994); Encyclopedia of Scent, Japan Pharmaceutical Association, Asakura Bookstore (1989); Perfumery Material Performance V. 3.3, Boelens Aroma Chemical Information Service (1996); Flower oils and Floral Compounds In Perfumery, Danute Lajaujis Anonis, Allured Pub. Co. (1993) etc. are mentioned, for example, The said pharmaceutical component can be selected suitably from the pharmaceutical raw materials as described in these documents. Specifically, eucalyptus oil, camphor, borneo, lemon oil, lime oil, grapefruit extract, lavender oil, lavender extract, rosemary oil, rosemary extract, etc. are mentioned, for example.

항료용 용제로서는, 예를 들면, 에탄올, 벤질벤조에이트, 아세틴(트리아세틴), MMB아세테이트(3-메톡시-3-메틸부틸아세테이트), 에틸렌글리콜디부틸레이트, 헥실렌글리콜, 디부틸세바케이트, 델틸엑스트라(이소프로필미리스테이트), 메틸카르비톨(디에틸렌글리콜모노메틸에테르), 카르비톨(디에틸렌글리콜모노에틸에테르), TEG(트리에틸렌글리콜), 안식향산 벤질, 프로필렌글리콜, 프탈산 디에틸, 트리프로필렌글리콜, 아볼린(디메틸프탈레이트), 델틸프라임(이소푸로필팔미테토), 디프로필렌글리콜 DPG-FC(디프로필렌글리콜), 파르네센, 디옥틸아디페이트, 트리부티린(글리세릴트리부타노에이트), 히드롤라이트-5(1,2-펜타디올), 프로필렌글리콜디아세테이트, 세틸아세테이트(헥사데실아세테이트), 에틸아비에테이트, 아발린(메틸아비에테이트), 시트로플렉스A-2(아세틸트리에틸시트레이트), 시트로플렉스A-4(트리부틸아세틸시트레이트), 시트로플렉스No.2(트리에틸시트레이트), 시트로플렉스No.4(트리부틸시트레이트), 도라픽스(메틸디히드로아비에테이트), MITD(이소트리데실미리스테이트), 폴리리모넨(리모넨 폴리머), 1,3-부틸렌글리콜 등을 들 수 있다. 항료용 용제의 함유량으로서는, 항료 조성물중 0.1 내지 99질량%가 바람직하고, 0.1 내지 10질량%가 보다 바람직하다.As a solvent for a pharmaceutical, For example, ethanol, benzyl benzoate, acetin (triacetin), MMB acetate (3-methoxy-3-methylbutyl acetate), ethylene glycol dibutylate, hexylene glycol, dibutyl seba Kate, deltyl extra (isopropyl myristate), methyl carbitol (diethylene glycol monomethyl ether), carbitol (diethylene glycol monoethyl ether), TEG (triethylene glycol), benzyl benzoate, propylene glycol, diethyl phthalate , Tripropylene glycol, abolin (dimethyl phthalate), deltyl prime (isopurophyl palmitto), dipropylene glycol DPG-FC (dipropylene glycol), farnesene, dioctyl adipate, tributyrin (glyceryl tributa Noate), hydrolite-5 (1,2-pentadiol), propylene glycol diacetate, cetyl acetate (hexadecyl acetate), ethyl abietate, avalin (methyl abietate), citraflo A-2 (acetyltriethyl citrate), citroplex A-4 (tributylacetyl citrate), citroplex No. 2 (triethyl citrate), citroflex No. 4 (tributyl citrate) ), Dorafix (methyldihydroaviate), MITD (isotridecyl myristate), polylimonene (limonene polymer), 1, 3- butylene glycol, etc. are mentioned. As content of a solvent for pharmaceuticals, 0.1-99 mass% is preferable in a pharmaceutical composition, and 0.1-10 mass% is more preferable.

항료 안정화제로서는, 예를 들면, 디부틸히드록시톨루엔, 부틸히드록시아니솔, 비타민E와 그 유도체, 카테킨 화합물, 플라보노이드 화합물, 폴리페놀 화합물등을 들 수 있고, 그 중에서도, 디부틸히드록시톨루엔이 바람직하다. 항료 안정화제의 함유량으로서는, 항료 조성물중 0.0001 내지 10질량%가 바람직하고, 0.001 내지 5질량%가 보다 바람직하다.As a pharmaceutical stabilizer, dibutylhydroxytoluene, butylhydroxyanisole, vitamin E, its derivative (s), a catechin compound, a flavonoid compound, a polyphenol compound, etc. are mentioned, for example, Dibutylhydroxytoluene This is preferred. As content of a chemical stabilizer, 0.0001-10 mass% is preferable in a pharmaceutical composition, and 0.001-5 mass% is more preferable.

청량제로서는, 멘톨, 페퍼민트 유, 박하 유 등을 들 수 있다. 구체적으로는, N-에틸파라멘탄카르복사미드(상품명 : WS3), l-멘틸글리세릴에테르(상품명 : CA-10), 멘틸락테이트(상품명 : FrescolatML, FrescolatMGA) 등을 들 수 있다.Menthol, peppermint oil, peppermint oil, etc. are mentioned as a refreshing agent. Specifically, N-ethyl paramentane carboxamide (brand name: WS3), l-menthyl glyceryl ether (brand name: CA-10), menthyl lactate (brand name: FrescolatML, FrescolatMGA), etc. are mentioned.

본 발명의 살균 청정제 조성물의 제조 방법으로서는, 상기 필수 성분, 임의 성분, 및 물(잔부)을 혼합하면 좋고, 특히 제한은 없고, 목적에 응하여 적절히 선택할 수 있다. 또한, 살균 청정제 조성물을 조제하는 장치로서는 특히 제한은 없고, 목적에 응하여 적절히 선택할 수 있고, 전단력과 전체 혼합할 수 있는 복수의 교반 날개(프로펠러, 터빈, 디스퍼 등)를 구비한 교반 장치가 바람직하다. 살균 청정제 조성물의 원료로서는 특히 제한은 없고, 목적에 응하여 적절히 선택할 수 있다. 또한, 각각의 원료를 단독으로 사용하여도 좋고, 각각의 원료를 포함하는 혼합물을 사용하여도 좋다.As a manufacturing method of the germicidal detergent composition of this invention, it is good to mix the said essential component, arbitrary components, and water (remainder), and there is no restriction | limiting in particular and it can select suitably according to the objective. Moreover, there is no restriction | limiting in particular as an apparatus which prepares a disinfecting detergent composition, The stirring apparatus provided with the some stirring blade (propeller, turbine, a disper etc.) which can be suitably selected according to the objective, and can be mixed with shearing force in whole is preferable. Do. There is no restriction | limiting in particular as a raw material of a sterilizing detergent composition, According to the objective, it can select suitably. In addition, each raw material may be used independently, and the mixture containing each raw material may be used.

본 발명의 살균 청정제 조성물의 pH는 4 내지 7이 바람직하다. 피부 마일드성의 점에서 이 범위가 바람직하고, pH7을 초과하면 방부력이 떨어질 우려가 있다. pH의 조정에는, 구연산과 구연산 나트륨을 사용하는 것이 바람직하다. 또한, 본 발명의 pH는, 25℃에서, pH미터(도아전파공업제 HM-30G), pH전극(동아디케케(주)제 GST-5721C형)를 이용하고 측정한 값이다.As for pH of the germicidal detergent composition of this invention, 4-7 are preferable. This range is preferable at the point of skin mildness, and when pH7 is exceeded, there exists a possibility that antiseptic force may fall. It is preferable to use citric acid and sodium citrate for adjustment of pH. In addition, the pH of this invention is the value measured using the pH meter (HM-30G by Toago Radio Industry Co., Ltd.), and a pH electrode (GST-5721C type by Dong Aikeke Co., Ltd.) at 25 degreeC.

본 발명의 살균 청정제 조성물은 상온에서 액체상(液體狀)이고, 사용하는 온도 조건하에서 살균 청정제 조성물의 점도는, 30mPa·s 이하가 바람직하고, 10mPa·s 이하가 보다 바람직하다. 또한, 본 발명의 점도는 온도(사용하는 온도 조건, 통상 25℃)에서, 회전점도계(도쿄계기(주)제, 형식 B8L)를 이용하여, No.1 로터 회전수 60rpm에서 60초 측정한 값이다.The germicidal cleaning agent composition of the present invention is liquid at room temperature, and the viscosity of the germicidal cleaning agent composition is preferably 30 mPa · s or less, more preferably 10 mPa · s or less under the temperature conditions to be used. In addition, the viscosity of this invention measured the value of 60 seconds at No.1 rotor rotation speed 60 degreeC using the rotational viscometer (former B8L made by Tokyo Instruments Co., Ltd.) at the temperature (temperature conditions to be used, 25 degreeC normally). to be.

본 발명의 살균 청정제 조성물은, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는, 씻어내지 않는 타입의 것이다. 거품형상이기 때문에, 겔상이나 스프레이상의 것보다도 사용하기 쉽고, 물이 없는 곳에서 간단하게 살균·세정을 행할 수가 있다. 또한, 씻어내지 않는 타입의 살균 청정제 조성물과, 이것을 수용하고 거품형상으로 토출시키는 포머 용기를 구비한 살균 청정제 제품으로 할 수도 있다.The sterilizing detergent composition of the present invention is of a type that is not washed out, which is formed by filling a former container and discharged in a foam form. Since it is in the form of a bubble, it is easier to use than gel or spray and can be easily sterilized and washed in the absence of water. Moreover, it can also be set as the germicidal detergent product which has the germicidal detergent composition of the type which does not wash away, and a foamer container which accommodates this and discharges it in foam form.

포머 용기로서는, 논가스형의 거품 토출 용기, 분사제(噴射劑)와 내압 용기를 사용하는 에어졸 용기를 들 수 있지만, 논가스형의 거품 토출 용기가 바람직하다. 논가스형의 거품 토출 용기로서는, 살균 청정제 조성물을 공기와 혼합하여 발포 상태로 토출할 수 있는 것이면 특히 한정되지 않고, 예를 들면, 보틀 동부(胴部)를 손으로 압착함에 의해 거품을 토출할 수 있는 스퀴즈 포머 용기, 노즐부를 압하함에 의해 거품을 토출할 수 있는 펌프 포머 용기 등을 들 수 있고, 목적에 응하여 적절히 선택할 수 있다. 이와 같은 포머 용기는, 야마토제관 주식회사제, 주식회사 요시노공업소제 등의 것을 사용할 수 있다. 보다 구체적으로는, 포머 용기로서는, 특개평7-315463호 공보, 특개평8-230961호 공보, 및 특개2005-193972호 공보에 기재된 포머 용기 등을 사용할 수 있다.As a foamer container, although the non-gas type bubble discharge container and the aerosol container using a propellant and a pressure-resistant container are mentioned, a non-gas type bubble discharge container is preferable. The non-gas type bubble discharge container is not particularly limited as long as it can mix the sterilizing detergent composition with air and discharge it in a foamed state. For example, bubbles can be discharged by squeezing the bottle eastern by hand. The squeeze foamer container which can be used, the pump foamer container which can discharge foam | bubble by pressing down a nozzle part, etc. are mentioned, It can select suitably according to the objective. As such a foamer container, things, such as a product made by Yamato-Kankan Co., Ltd., Yoshino Corporation, etc., can be used. More specifically, as a former container, the former container of Unexamined-Japanese-Patent No. 7-315463, 8-230961, Unexamined-Japanese-Patent No. 2005-193972, etc. can be used.

논가스형의 거품 토출 용기는 거품 형성 부재를 가지며, 구체적으로는, 거품을 형성하기 위한 다공질막체(多孔質膜體)(재질은 나일론, 폴리에스테르, 폴리올레핀 등의 플라스틱 재료가 바람직하다)를 가지며, 살균 청정제 조성물이 그 다공질막체를 통과함에 의해 거품이 형성되는 것이다. 다공질막체의 메시로서는, 특히 제한은 없고, 목적에 응하여 적절히 선택할 수 있고, 예를 들면, 100메시 이상이 바람직하고, 100 내지 400메시가 보다 바람직하고, 200 내지 305메시가 특히 바람직하다. 또한, 다공질막체의 매수로서는 특히 제한은 없고, 목적에 응하여 적절히 선택할 수 있고, 거품 성능을 향상시키는 관점에서 2 내지 4장이 바람직하다. 것보다 구체적으로는, 특개평7-315463호 공보, 특개평8-230961호 공보, 및 특개2005-193972호 공보에 기재된 포머 용기를 알맞게 사용할 수 있다. 예를 들면, 노즐부를 압하함에 의해 거품을 토출할 수 있는 펌프 포머 용기와 305, 200메시 각 1장 사용할 때에 있어서, 사용하는 온도 조건하에서 살균 청정제 조성물의 점도는, 30mPa·s 이하가 바람직하고, 10mPa·s 이하가 보다 바람직하다.The non-gas type bubble discharge container has a bubble forming member, and specifically, has a porous membrane body (preferably a plastic material such as nylon, polyester or polyolefin) for forming bubbles. As the sterilizing detergent composition passes through the porous membrane body, bubbles are formed. There is no restriction | limiting in particular as a mesh of a porous membrane body, According to the objective, it can select suitably, For example, 100 mesh or more is preferable, 100-400 mesh is more preferable, 200-305 mesh is especially preferable. There is no restriction | limiting in particular as the number of sheets of a porous membrane body, 2-4 pieces are preferable from a viewpoint of selecting suitably according to the objective, and improving foaming performance. More specifically, the former container of Unexamined-Japanese-Patent No. 7-315463, 8-230961, and 2005-193972 can be used suitably. For example, when using a pump former container which can discharge foam by pressing down a nozzle part, and each of 305 and 200 mesh, the viscosity of a sterilizing detergent composition is 30 mPa * s or less under the temperature conditions to be used, 10 mPa * s or less is more preferable.

본 발명에 있어서, 씻어내지 않는 타입이란, 거품형상의 살균 청정제 조성물을 손에 취하여, 살균 청정 대상, 예를 들면 손, 전신 등의 피부에 편 후, 물 등으로 씻어내지 않고 사용하는 것을 말한다. 사용 방법으로서는 특히 한정되지 않지만, 1일 수회, 적량 1 내지 15g를 거품형상으로 하여 손에 취하고, 살균 청정 대상, 예를 들면 손, 전신 등에 골고루 미치게 하는 방법 등을 들 수 있다.In the present invention, the type that does not wash off refers to a foamy sterilizing detergent composition obtained by hand, and used on the skin of a sterilizing and cleansing object, for example, a hand or the whole body, without being washed with water or the like. Although it does not specifically limit as a usage method, The method of taking a proper quantity 1-15 g in foam form several times a day, making it into a hand, and evenly spreading to a sterilization clean object, for example, a hand, the whole body, etc. is mentioned.

실시예Example

이하, 실시예 및 비교예를 나타내여, 본 발명을 구체적으로 설명하지만, 본 발명은 하기한 실시예로 제한된 것이 아니다. 또한, 하기한 예에 있어서 특히 명기가 없는 경우는, 조성의 %는 질량%, 비율은 질량비를 나타내고, 실시예 기재된 성분량은 전부 순분(純分) 환산이다.Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not limited to the following Example. In addition, in the following example, when there is no specified in particular,% of a composition shows the mass%, a ratio shows the mass ratio, and all the component amounts described in the Example are pure part conversion.

[실시예 1 내지 67, 비교예 1 내지 17][Examples 1 to 67, Comparative Examples 1 to 17]

표 1 내지 14에 표시하는 조성의 살균 청정제 조성물을 일상법에 준하여 조제하고, 조성물의 pH를 약 5.6으로 조정하였다. 실시예의 살균 청정제 조성물의 점도(25℃)를, 회전점도계(도쿄계기(주)제, 형식 B8L)을 이용하여, No.1 로터 회전수 60rpm으로 60초 측정한 바, 1 내지 9mPa·s였다. 얻어진 살균 청정제 조성물 250mL의 포머 용기에 200g 충전하였다. 이 포머 용기의 스펙은 특개2005-193972호 공보에 기재된 방법에 준거하고, 상품명 W-5721, WP. FT L노즐(요시노공업소제)의 것을 사용하였다. 구체적으로는, 기/액의 용적비 : 13/1, 토출량 : 1g(1푸시), 구경은 5㎜×8㎜(타원형상), 거품 형성 부재 : 200메시와 305메시의 다공질막체 각 1장씩의 것을 사용하였다.The sterile detergent composition of the composition shown to Tables 1-14 was prepared according to the routine method, and the pH of the composition was adjusted to about 5.6. It was 1-9 mPa * s when the viscosity (25 degreeC) of the sterilizing detergent composition of an Example was measured for 60 second at No.1 rotor rotation speed using the rotational viscometer (made by Tokyo Instruments Co., Ltd., model B8L). . 200 g was filled in the former container of 250 mL of the obtained sterilizing detergent composition. The specification of this former container is based on the method of Unexamined-Japanese-Patent No. 2005-193972, and is brand name W-5721, WP. The FT L nozzle (made by Yoshino Corporation) was used. Specifically, the volume ratio of the gas / liquid: 13/1, the discharge amount: 1 g (1 push), the aperture is 5 mm x 8 mm (elliptical shape), the foaming member: 200 mesh and each one of the 305 mesh porous membrane body Was used.

[거품의 보형성][Formation of foam]

25℃·60%RH의 조건하에서, 폴리염화 비닐리덴 필름상(上)에, 포머 용기로부터 거품형상의 살균 청정제 조성물 1g를 토출시키고, 토출 30초 후의 거품 높이를 측정하였다. 이 평가방법에 있어서, 5㎜ 미만의 것은 거품의 보형성이 나쁘고 손에 취한 때에 잘 떨어지고, 20㎜ 이상의 경우는, 손에 취한 거품이 적당한 시간에 사라지지 않고, 손에 문질러 바르기 어렵다. 즉, 사용성상 바람직한 거품 보형성 및 적당한 소포(消泡) 시간으로서는, 이 평가방법에서, 5㎜ 이상 20㎜ 미만의 것이다. 결과는, 3회 측정한 평균치에 의거하여, 이하의 판정 기준으로 나타내였다.Under conditions of 25 ° C. and 60% RH, 1 g of a foamy sterilizing detergent composition was discharged from the foamer container onto the polyvinylidene chloride film, and the bubble height after 30 seconds after the discharge was measured. In this evaluation method, the thing less than 5 mm falls poorly in the case of poor foam retention, and when it is 20 mm or more, the bubble taken by hand does not disappear at a suitable time, and it is hard to rub it on a hand. That is, in terms of usability, preferred foam retaining properties and suitable defoaming times are 5 mm or more and less than 20 mm in this evaluation method. The result was shown by the following criteria based on the average value measured 3 times.

〈판정 기준〉<Criteria>

◎ : 16㎜ 이상 20㎜ 미만◎: 16 mm or more and less than 20 mm

○ : 13㎜ 이상 16㎜ 미만○: 13 mm or more and less than 16 mm

△ : 5㎜ 이상 13㎜ 미만△: 5 mm or more and less than 13 mm

× : 5㎜ 미만 또는 20㎜ 이상X: less than 5 mm or 20 mm or more

[손을 맞비빈 후의 거품 찌꺼기 없음][No bubble after hand rubs]

25℃·60%RH의 조건하에서, 포머 용기로부터 거품형상의 살균 청정제 조성물 1g를, 손에 토출시키고, 약 10초간 손을 맞비빈 후, 손바닥 위의 거품 찌꺼기을 평가하였다. 결과는, 전문 패널 10명이 하기 평점으로 관능 평가하고, 그 평점의 평균치에 의거하여, 하기 판정 기준으로 나타내였다.Under conditions of 25 ° C. and 60% RH, 1 g of a foamy sterilizing detergent composition was discharged from the foamer container into the hands, and the hands were rubbed for about 10 seconds, and then the foam residue on the palms was evaluated. The result was sensory evaluation by ten professional panelists with the following rating, and was shown by the following criteria of criterion based on the average value of the rating.

〈평점〉<grade>

5점 : 전혀 거품 찌꺼기가 없다(허용 범위 내)5 points: no bubble residue at all (within the allowable range)

4점 : 거의 거품 찌꺼기가 없다(허용 범위 내)4 points: Almost no bubble dregs (within the permissible range)

3점 : 약간 거품 찌꺼기가 있다(허용 범위 내)3 points | pieces: There is a little bubble dregs (within the permissible range)

2점 : 상당히 거품 찌꺼기가 있다(허용 범위 외)2 points | pieces: There is considerably bubble dregs (outside tolerance)

1점 : 거품이 증가하여 온다(허용 범위 외)1 point: Bubbles increase (outside the acceptable range)

〈판정 기준〉<Criteria>

◎ : 4.0 이상◎: 4.0 or more

○ : 3.0 이상 4.0 미만○: 3.0 or more and less than 4.0

△ : 2.0 이상 3.0 미만△: 2.0 or more and less than 3.0

× : 2.0 미만×: less than 2.0

[건조 용이성][Ease of Drying]

25℃·60%RH의 조건하에서, 포머 용기로부터 거품형상의 살균 청정제 조성물 1g를, 손에 토출시키고, 손 및 손등에 문질러 바르면서 액이 마르기까지의 시간을 측정하였다. 결과는, 전문 패널 10명이 관능 평가하고, 그 시간의 평균치에 의거하여, 하기 판정 기준으로 나타내였다.Under the conditions of 25 ° C. and 60% RH, 1 g of the foam-type sterilizing detergent composition was discharged from the foamer container into the hand, and the time until the liquid dries was measured while rubbing on the back of the hand and the hand. The result was sensory evaluation by ten professional panels, and was shown by the following determination criteria based on the average value of the time.

〈판정 기준〉<Criteria>

◎ : 30초 미만(허용 범위 내)◎: less than 30 seconds (within the allowable range)

○ : 30초 이상 60초 미만(허용 범위 내)○: 30 seconds or more but less than 60 seconds (within the allowable range)

△ : 60초 이상 90초 미만(허용 범위 외)△: 60 seconds or more and less than 90 seconds (outside the allowable range)

× : 90초 이상(허용 범위 외)×: 90 seconds or more (outside the allowable range)

[살균력(감균률(減菌率)(%)][Sterilization (sterilization rate (減 菌 率) (%)]]

한쪽손의 3개의 손가락을 표준 한천 배지(培地)(일본제약(주)제)에 플레이팅하여 사용 전의 세균을 채취하였다. 그 후, 다른쪽손에 살균 청정제 조성물 1g를 취하고, 즙이 마를 때까지 손가락에 문질러 바른 후, 표준 한천 배지에 3개의 손가락을 플레이팅하여, 사용 후의 세균을 채취하였다(스트리크 플레이트법). 살균 청정제 조성물 사용 전후의 손가락의 균을, 37℃에서 24시간 배양한 후 콜로니수를 측정하였다. 이하의 식에 따라, 사용 전 콜로니수(A0), 사용 후 콜로니수(A1)로부터 감균률을 나타내였다. 감균률 95% 이상의 것이 유효하고, 70% 미만은 무효이다.Three fingers of one hand were plated on a standard agar medium (manufactured by Nippon Pharmaceutical Co., Ltd.) to collect bacteria before use. Thereafter, 1 g of sterile detergent composition was taken on the other hand, rubbed on the finger until the juice dries, and then three fingers were plated on a standard agar medium to collect the used bacteria (Strike plate method). Colonies of fingers before and after use of the sterilizing detergent composition were incubated at 37 ° C. for 24 hours, and the number of colonies was measured. , Number of colonies before use (A 0) according to the following equation, and then the sense of use was shown gyunryul from the colony number (A 1). It is effective to have a sterilization rate of 95% or more and less than 70%.

감균률(%)=(1-A1/A0)×100Infection Rate (%) = (1-A 1 / A 0 ) × 100

[표 1]TABLE 1

Figure pct00004
Figure pct00004

*1 : 알킬쇄(鎖) 길이(R1)는 C12/C14=63/37(질량비)* 1: The alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

*2 : 알킬쇄 길이(R2)는 C16* 2: alkyl chain length (R 2 ) is C16

*3 : 에테르 결합을 갖는 탄화 수소기(R1)는 C18H29O2 * 3: A hydrocarbon group having an ether bond (R 1 ) is C 18 H 29 O 2

[표 2]TABLE 2

Figure pct00005
Figure pct00005

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 3][Table 3]

Figure pct00006
Figure pct00006

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 4][Table 4]

Figure pct00007
Figure pct00007

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 5]TABLE 5

Figure pct00008
Figure pct00008

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 6]TABLE 6

Figure pct00009
Figure pct00009

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

*2 : 알킬쇄 길이(R2)는 C16* 2: alkyl chain length (R 2 ) is C16

[표 7]TABLE 7

Figure pct00010
Figure pct00010

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

*2 : 알킬쇄 길이(R2)는 C16* 2: alkyl chain length (R 2 ) is C16

*3 : 에테르 결합을 갖는 탄화 수소기(R1)는 C18H29O2 * 3: A hydrocarbon group having an ether bond (R 1 ) is C 18 H 29 O 2

[표 8][Table 8]

Figure pct00011
Figure pct00011

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 9]TABLE 9

Figure pct00012
Figure pct00012

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

*2 : 알킬쇄 길이(R2)는 C16* 2: alkyl chain length (R 2 ) is C16

*3 : 에테르 결합을 갖는 탄화 수소기(R1)는 C18H29O2 * 3: A hydrocarbon group having an ether bond (R1) is C 18 H 29 O 2

[표 10]TABLE 10

Figure pct00013
Figure pct00013

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 11]TABLE 11

Figure pct00014
Figure pct00014

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 12]TABLE 12

Figure pct00015
Figure pct00015

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[표 13]TABLE 13

Figure pct00016
Figure pct00016

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

*2 : 알킬쇄 길이(R2)는 C16* 2: alkyl chain length (R 2 ) is C16

[표 14][Table 14]

Figure pct00017
Figure pct00017

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

[실시예 68]Example 68

하기한 조성에 따라, 일상법에 의해 실시예 68의 전신용 살균 청정제 조성물을 조제하였다. 얻어진 전신용 살균 청정제 조성물에 관해, 실시예 1과 마찬가지로 포머 용기에 충전하고, 마찬가지로 평가를 행하였다. (pH5.6, 점도(25℃), 4mPa·s)According to the following composition, the systemic sterilizing detergent composition of Example 68 was prepared by the routine method. The obtained whole body sterilizing detergent composition was filled in the former container similarly to Example 1, and it evaluated similarly. (pH5.6, viscosity (25 ° C), 4 mPas)

[표 15]TABLE 15

조성 %Furtherance %

염화 벤잘코늄 *1 0.05Benzalkonium Chloride * 1 0.05

폴리옥시에틸렌(60) 경화피마자유(HLB14) 0.5Polyoxyethylene (60) hardened castor oil (HLB14) 0.5

dl-피롤리돈카르본산 나트륨 0.5dl-pyrrolidone carbonate 0.5

글리시리진산 2칼륨 0.25Dipotassium glycyrrhizinate 0.25

에틸알코올 20Ethyl alcohol 20

구연산 0.25Citric Acid 0.25

구연산 나트륨 0.7Sodium Citrate 0.7

정제수 잔부Purified water balance

----------------------------------------------------------------------------------------------------- -

합계 100.0100.0 total

*1 : 알킬쇄 길이(R1)는 C12/C14=63/37(질량비)* 1: alkyl chain length (R 1 ) is C12 / C14 = 63/37 (mass ratio)

(평가 결과)(Evaluation results)

거품의 보형성 : ◎Foam Formation: ◎

손을 맞비빈 후의 거품 찌꺼기 없음 : ◎No lather after hand rub: ◎

건조 용이성 : ○Ease of Drying: ○

감균률 : 99%
Infection Rate: 99%

실시예 및 비교예를 조제할 때에 사용한 원료를 이하에 나타낸다.The raw material used when preparing the Example and the comparative example is shown below.

(1) 염화 벤잘코늄 : 일유(주)제, 닛산 카티온 F2-50E(1) Benzalkonium Chloride: Nissan Cation F2-50E

*1 : 알킬쇄 길이(R1)는, C12/C14=63/37(질량비)* 1: The alkyl chain length (R 1 ) is C 12 / C 14 = 63/37 (mass ratio)

(2) 염화 세틸피리디늄 : 와코준야쿠공업(주)제, 염화 세틸피리디늄(2) Cetylpyridinium Chloride: Wakojunyaku Industry Co., Ltd., cetylpyridinium chloride

*2 : 알킬쇄 길이(R2)는, C16* 2: Alkyl chain length (R 2 ) is C16

(3) 염화 벤제토늄 : 미쓰비시화학 푸드(주)제 하이아민 결정(結晶)(3) Benzetonium chloride: crystals of hyamine from Mitsubishi Chemical Foods Co., Ltd.

*3 : 에테르 결합을 갖는 탄화 수소기(R1)는 C18H29O2 * 3: A hydrocarbon group having an ether bond (R 1 ) is C 18 H 29 O 2

(4) 폴리옥시에틸렌(20) 경화피마자유(PEG-20 경화피마자유) : 일본에멀션(주)제, EMALEX HC-20(4) Polyoxyethylene (20) Cured castor oil (PEG-20 Cured castor oil): Japan Emulsion Co., Ltd., EMALEX HC-20

(5) 폴리옥시에틸렌(40) 경화피마자유(PEG-40 경화피마자유) : 일본에멀션(주)제, EMALEX HC-40(5) Polyoxyethylene (40) hardened castor oil (PEG-40 hardened castor oil): Japan Emulsion Co., Ltd., EMALEX HC-40

(6) 폴리옥시에틸렌(60) 경화피마자유(PEG-60 경화피마자유) : 일본에멀션(주)제, EMALEX HC-60(6) Polyoxyethylene (60) hardened castor oil (PEG-60 hardened castor oil): Japan Emulsion Co., Ltd., EMALEX HC-60

(7) 폴리옥시에틸렌(100) 경화피마자유(PEG-100 경화피마자유) : 일본에멀션(주)제, EMALEX HC-100(7) Polyoxyethylene (100) Cured Castor Oil (PEG-100 Cured Castor Oil): Japan Emulsion Co., Ltd., EMALEX HC-100

(8) 스테아린산 PEG-10 : 일본에멀션(주)제, EMALEX810(8) Stearic acid PEG-10: Japan Emulsion Co., Ltd., EMALEX810

(9) 스테아린산 PEG-20 : 일본에멀션(주)제, EMALEX820(9) Stearic acid PEG-20: Japan Emulsion Co., Ltd., EMALEX820

(10) 스테아린산 PEG-40 : 일본에멀션(주)제, EMALEX840(10) Stearic acid PEG-40: Japan Emulsion Co., Ltd., EMALEX840

(11) 스테아린산 PEG-10 글리세릴 : 일본에멀션(주)제, EMALEX GM-10(11) stearic acid PEG-10 glyceryl: Japan Emulsion Co., Ltd., EMALEX GM-10

(12) 스테아린산 PEG-15 글리세릴 : 일본에멀션(주)제, EMALEX GM-15(12) stearic acid PEG-15 glyceryl: Japan Emulsion Co., Ltd., EMALEX GM-15

(13) 스테아린산 PEG-40 글리세릴 : 일본에멀션(주)제, EMALEX GM-40(13) Stearate PEG-40 Glyceryl: Japan Emulsion Co., Ltd., EMALEX GM-40

(14) dl-피롤리돈카르본산 나트륨 아지노모토(주)제, PCA 소다(14) dl-pyrrolidone carboxylic acid sodium Ajinomoto Co., Ltd. make, PCA soda

(15) 리신 : 아지노모토(주)제, 염산 L-리신(15) Lysine: Ajinomoto Co., Ltd., hydrochloric acid L-lysine

(16) 세린 : 교와발효공업(주)제, L-세린(16) Serine: Kyowa Fermentation Co., Ltd., L-serine

(17) 폴리옥시에틸렌(10) 경화피마자유(PEG-10 경화피마자유) : 일본에멀션(주)제, EMALEX HC-10(17) Polyoxyethylene (10) Cured castor oil (PEG-10 Cured castor oil): Japan Emulsion Co., Ltd., EMALEX HC-10

(18) 스테아린산 PEG-150 : 일본에멀션(주)제, EMALEX 6300M-ST(18) Stearic acid PEG-150: Japan Emulsion Co., Ltd., EMALEX 6300M-ST

(19) 이미다조리늄베타인 : 동방화학공업(주)제, 오바조린662N(19) imidazolinium betaine: Ovazorin 662N, manufactured by Dongbu Chemical Co., Ltd.

(20) 폴리옥시에틸렌(10) 콜레스테릴에테르 : 일본에멀션(주)제, EMALEX CS-10(20) Polyoxyethylene (10) cholesteryl ether: Japan Emulsion Co., Ltd., EMALEX CS-10

(21) 폴리옥시에틸렌(15) 데실테트라데실에테르 : 일본에멀션(주)제, EMALEX 2415(21) Polyoxyethylene (15) decyl tetradecyl ether: Japan Emulsion Co., Ltd., EMALEX 2415

(22) 폴리옥시에틸렌(10) 옥틸도데실에테르 : 일본에멀션(주)제, EMALEX OD-10(22) Polyoxyethylene (10) octyldodecyl ether: Japan Emulsion Co., Ltd., EMALEX OD-10

(23) 폴리옥시에틸렌(20) 옥틸도데실에테르 : 일본에멀션(주)제, EMALEX OD-20(23) Polyoxyethylene (20) octyldodecyl ether: Japan Emulsion Co., Ltd., EMALEX OD-20

(24) 폴리옥시에틸렌(25) 옥틸도데실에테르 : 일본에멀션(주)제, EMALEX OD-25(24) Polyoxyethylene (25) octyldodecyl ether: Japan Emulsion Co., Ltd., EMALEX OD-25

(25) 폴리옥시에틸렌(5) 콜레스테릴에테르 : 일본에멀션(주)제, EMALEX CS-5(25) Polyoxyethylene (5) cholesteryl ether: Japan Emulsion Co., Ltd., EMALEX CS-5

(26) 폴리옥시에틸렌(10) 데실테트라데실에테르 : 일본에멀션(주)제, EMALEX 2410(26) Polyoxyethylene (10) decyl tetradecyl ether: Japan Emulsion Co., Ltd., EMALEX 2410

(27) 폴리옥시에틸렌(20) 이소세틸에테르 : 일본에멀션(주)제, EMALEX 1620(27) Polyoxyethylene (20) isocetyl ether: Japan Emulsion Co., Ltd., EMALEX 1620

Claims (3)

(A) 카티온성 살균제, (B-1) HLB9 내지 16의 폴리옥시에틸렌 경화피마자유, 모노스테아린산 폴리옥시에틸렌글리세린 및 모노스테아린산 폴리에틸렌글리콜로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 16 내지 40질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물.(A) a cationic fungicide, (B-1) nonionic surfactant selected from polyoxyethylene hardened castor oil of HLB9-16, monostearic acid polyoxyethyleneglycerin and monostearic acid polyethyleneglycol, (C) amino acid or its salt, And (D) 16 to 40% by mass of alcohols having 1 to 3 carbon atoms, which are filled in a former container and discharged in the form of bubbles, wherein the disinfecting detergent composition of the non-washable type is used. (A) 카티온성 살균제, (B-2) HLB10 내지 14의 하기 일반식(1)
Figure pct00018

(식 중, m은 6 내지 10, n은 10 내지 25의 정수를 나타낸다.)
로 표시되는 폴리옥시에틸렌 분기 알킬에테르 및 폴리옥시에틸렌콜레스테릴에테르로부터 선택되는 비이온성 계면활성제, (C) 아미노산 또는 그 염, 및 (D) 탄소수 1 내지 3의 알코올 30 내지 70질량%를 함유하고, 포머 용기에 충전하여 이루어지고 거품형상으로 토출되는 것을 특징으로 하는, 씻어내지 않는 타입의 살균 청정제 조성물.
(A) Cationic fungicide, (B-2) the following general formula (1) of HLB10-14
Figure pct00018

(In formula, m is 6-10, n represents the integer of 10-25.)
Nonionic surfactants selected from polyoxyethylene branched alkyl ethers and polyoxyethylene cholesteryl ethers, (C) amino acids or salts thereof, and (D) 30 to 70 mass% of alcohols having 1 to 3 carbon atoms. A sterilizing detergent composition of a non-washable type, characterized in that it is filled into a former container and discharged in a foam form.
제 1항 또는 제 2항에 있어서,
(A)성분이, 염화 벤잘코늄, 염화 벤제토늄 또는 염화 세틸피리디늄인 것을 특징으로 하는 살균 청정제 조성물.
3. The method according to claim 1 or 2,
(A) A component is benzalkonium chloride, benzetonium chloride, or cetylpyridinium chloride, The sterilizing detergent composition characterized by the above-mentioned.
KR1020107013334A 2007-12-12 2008-10-27 Bactericidal cleanser composition KR101443951B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007320531 2007-12-12
JPJP-P-2007-320531 2007-12-12
PCT/JP2008/069407 WO2009075142A1 (en) 2007-12-12 2008-10-27 Bactericidal cleanser composition

Publications (2)

Publication Number Publication Date
KR20100106975A true KR20100106975A (en) 2010-10-04
KR101443951B1 KR101443951B1 (en) 2014-09-23

Family

ID=40755387

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107013334A KR101443951B1 (en) 2007-12-12 2008-10-27 Bactericidal cleanser composition

Country Status (6)

Country Link
JP (1) JP5343857B2 (en)
KR (1) KR101443951B1 (en)
CN (1) CN101896595B (en)
HK (1) HK1145511A1 (en)
MY (1) MY155282A (en)
WO (1) WO2009075142A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009029200A1 (en) * 2009-09-04 2011-03-17 Wacker Chemie Ag Isocyanate-free silane-crosslinking compositions
JP5583385B2 (en) * 2009-11-04 2014-09-03 大日本除蟲菊株式会社 disinfectant
JP5700558B2 (en) * 2011-11-02 2015-04-15 ライオン株式会社 Sheet cosmetic
JP6510177B2 (en) * 2014-04-01 2019-05-08 ロレアル Compositions in the form of nano or microemulsions
EP3132804B1 (en) * 2014-04-17 2021-05-05 Seed Co., Ltd. Medical device including anionic drug
JP6537788B2 (en) 2014-06-25 2019-07-03 ロレアル Composition in the form of a nanoemulsion or microemulsion or having a lamellar structure
CN104974859B (en) * 2015-06-29 2017-12-22 陈士友 Waterless carwash liquid
JP6281144B2 (en) * 2016-06-22 2018-02-21 石原ケミカル株式会社 Cleaning composition for car air conditioner and aerosol composition using the same
WO2019130748A1 (en) * 2017-12-28 2019-07-04 ライオン株式会社 Non-rinse-off liquid bactericidal cleaning agent
JP7300139B2 (en) * 2018-07-18 2023-06-29 株式会社日本色材工業研究所 oily cosmetics
CN110201603B (en) * 2019-06-13 2021-08-13 湖南华腾制药有限公司 Cationic surfactant and preparation method thereof
JP7345886B2 (en) * 2020-05-25 2023-09-19 株式会社東洋新薬 Alcohol-containing composition
JP7516327B2 (en) * 2021-09-02 2024-07-16 花王株式会社 Disinfection products

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06279268A (en) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd Disinfecting and sterilizing agent and aerosol composition containing the same
JP3093981B2 (en) * 1996-04-05 2000-10-03 花王株式会社 Detergent composition
TW427912B (en) * 1996-12-20 2001-04-01 Kao Corp Detergent composition
TW401307B (en) * 1996-12-20 2000-08-11 Kao Corp Detergent composition
JPH10330799A (en) * 1997-06-04 1998-12-15 Lion Corp Frothy bactericidal detergent composition
JP2001139993A (en) 1999-11-17 2001-05-22 Fumakilla Ltd Disinfection detergent for skin
JP4025950B2 (en) * 2000-04-28 2007-12-26 ライオン株式会社 Bactericidal compound-containing composition
JP5041113B2 (en) * 2001-08-20 2012-10-03 ライオン株式会社 Liquid detergent composition

Also Published As

Publication number Publication date
JPWO2009075142A1 (en) 2011-04-28
WO2009075142A1 (en) 2009-06-18
JP5343857B2 (en) 2013-11-13
HK1145511A1 (en) 2011-04-21
MY155282A (en) 2015-09-30
KR101443951B1 (en) 2014-09-23
CN101896595A (en) 2010-11-24
CN101896595B (en) 2012-04-25

Similar Documents

Publication Publication Date Title
KR20100106975A (en) Bactericidal cleanser composition
JP4527655B2 (en) Cleaner composition in former container
EP0117889B1 (en) Foamable denture cleanser and deodorant
JP4868148B2 (en) Liquid detergent product
JP5071687B2 (en) Liquid detergent composition for former container
JP5522828B2 (en) Skin cleanser
JP2012107147A (en) Liquid cleaning agent composition contained in foamer container
JP2010280588A (en) Coating-type liquid denture cleanser composition
JP4546069B2 (en) Non-gas type liquid detergent composition in foam discharge container
JP6237172B2 (en) Liquid detergent composition
JP5392043B2 (en) Denture cleaning liquid composition
JP6134837B1 (en) Liquid detergent composition
JP5801525B2 (en) Liquid detergent composition
JP2014009201A (en) Leave-in bactericidal cleanser composition
GB2481183A (en) Post-foaming cleansing composition
JP5695339B2 (en) Aqueous composition in a container
JP2004231543A (en) Cosmetic
JP7475845B2 (en) Cleansing agent
JP2023515314A (en) Isotropic concentrate and cleaning compositions
JP6451392B2 (en) Oral composition
JP7516327B2 (en) Disinfection products
JP2012193153A (en) Liquid or liquid-form oral composition and agent for inhibiting adherence of tongue coating
TW201920643A (en) Detergent composition
JP6688072B2 (en) Liquid oral composition
JP2023146622A (en) Method for producing liquid disinfectant composition

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170818

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180816

Year of fee payment: 5